Top Markets
Coin of the day
Satsuma Pharmaceuticals, Inc. Satsuma Pharmaceuticals, Inc.

Satsuma Pharmaceuticals, Inc.

STSA
Kedudukan dalam Saham #29898
Satsuma Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical firm... Satsuma Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical firm dedicated to developing innovative therapies for the rapid relief of migraines. Its lead therapeutic candidate, STS101, is an integrated drug-device system comprising a proprietary dry-powder formulation of dihydroergotamine mesylate. Currently, STS101 is progressing through its pivotal SUMMIT Phase 3 efficacy trials and is designed for self-administration via a specialized, pre-filled, single-use nasal delivery device. Established in 2016, the company maintains its headquarters in South San Francisco, California.
Harga Saham
$1.10
Disegerakkan terakhir: 2023-06-07
Modal Pasaran
$19.12M
Perubahan (1 hari)
-0.90%
Perubahan (1 tahun)
0.00%
Negara
US
Perdagangan Satsuma Pharmaceuticals, Inc. (STSA)

Kategori

Sejarah harga saham bagi Satsuma Pharmaceuticals, Inc. (STSA)
Harga penutupan tertinggi: $1.08 pada 2023-06-01

Harga penutupan terendah: $15.51 pada 2019-09-01
Sejarah harga saham Satsuma Pharmaceuticals, Inc. dari 2019 hingga 2026
Prestasi harga saham tahunan
Tahun Prestasi
2023 24.48%
2022 -81.02%
2021 -5.23%
2020 -69.52%
2019 0.00%
Harga saham bagi syarikat atau pesaing serupa
Syarikat Harga saham Perubahan 1thn% Negara
$527.89 35.09%
US
$996.61 51.72%
NL
$117.42 -19.34%
AU
$737.68 6.34%
CH
$1.07K -5.58%
KR